Scientists create new strain of polio to protect vaccine factory workers

"Scientists have created new strains of polio intended to protect workers in factories that make polio vaccine," the New York Times reports. "The new strains have the same ability to invoke an immune reaction as the live viruses now used to make vaccine do, but there is virtually no risk anyone will get polio if one of the new strains somehow escapes," the newspaper notes, adding, "The research team, at the State University of New York at Stonybrook, is led by Eckard A. F. Wimmer, a molecular geneticist who made headlines in 1991 when he synthesized polio virus in the lab from its chemical components, the first time a virus had been made outside of living cells."

"Currently, factories making the injectable Salk vaccine used in the United States and Europe start with the dangerous wild-type viruses known as Types 1, 2 and 3," the New York Times notes. "After growing a large batch, vaccine makers 'kill' the virus with formaldehyde and prepare it for syringes," the newspaper writes, adding, "The finished product is safe, but if the growing live viruses ever escaped 'because of a leak, an explosion, an earthquake, a tsunami, a flood,' Dr. Wimmer said, 'the spill could spread like wildfire'" (McNeil, 2/18).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
HPV vaccine linked to significant decline in cervical cancer mortality